Meeting
2017 Gastrointestinal Cancers Symposium
Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.
Authors
Kyung-Hun Lee
Seoul National University Hospital, Seoul, South Korea
Kyung-Hun Lee , Dae-Won Lee , Myoung-Jin Jang , Tae-Yong Kim , Sae-Won Han , Do-Youn Oh , Seock-Ah Im , Tae-You Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 454)
DOI
10.1200/JCO.2017.35.4_suppl.454
Abstract #
454
Poster Bd #
L16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Surrogate endpoints for overall survival in advanced hepatocellular carcinoma: A meta-analysis.
First Author: Yacob Saleh
Poster
2023 ASCO Annual Meeting
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.
First Author: Carles Fabregat Franco
Poster
2024 ASCO Genitourinary Cancers Symposium
Pembrolizumab plus lenvatinib (P+L) versus alternate therapies in first-line (1L) for advanced renal cell carcinoma (aRCC): A network meta-analysis (NMA).
First Author: Kevin Yan
Poster
2022 ASCO Annual Meeting
Candidate surrogate endpoints in advanced prostate cancer: Aggregate meta-analysis of 143 randomized trials.
First Author: Laila A Gharzai